The Coronavirus is a serious global public health threat with rapidly evolving information. Indiana has confirmed its first deaths from COVID-19.  IHIF Member companies, as employers, are developing policies in response to employee concerns and safety needs. In support, IHIF is working with other state groups and our partners at BIO, PhRMA, and AdvaMed to gather valuable tools and information for our Members to use as resources and guidelines. We particularly thank BioNJ for their efforts in organizing and presenting this information.

Deadline Extended – Please CLICK HERE to take our brief business survey to help assess the impact of COVID-19 by March 30. Results will be posted in the Toolbox.

How the biopharma and device industries are leading the charge in the fight against the Corona virus:

We are proud of how quickly America’s life science industry has stepped forward to develop antiviral therapies, vaccines, devices, and diagnostic tools to address this quickly spreading illness. Through the combined resources of our industry, working together with Congress, we are optimistic that an effective treatment can be identified to address this pandemic.

Local News:

Business and Community Resources

**BIO has launched hub.bio.orgIt’s a new platform for companies to post what information and supplies they need and what they can share, from RNA kits to pipette tips to general information and guidance. Read FAQ Here

What Comes Next

Colliers: “The Impact of SARS-CoV-2 on the Life Sciences Real Estate Sector” — addresses five immediate trends we expect to see as we navigate COVID-19. (register to download)

When will we have a vaccine? Geth the latest I AM BIO Podcast, featuring two of the MVPs of the COVID-19 fight: Stéphane Bancel, CEO of Moderna Inc., and former CDC Director Dr. Julie Gerberding, EVP and Chief Patient Officer of Merck. (1 hr)